Breakfast seminar march 18th

Drug safety development launch and beyond

Safety is a critical element for the entire life cyclo of a drug, there is an increasing regulatory preassure and public focus on safety.

Handling of adverse event data in an optimal and efficient manner and at the same time comply with the current legislations is a challenge.

 

Selecting the Optimal CRO

CRO´s involvment is important to conduct cost-effective and time efficient trials. the number of CRO´s is growing and the choice becomes harder. What should companies consider when selecting a CRO partner?

 

Speaker: Emma Wiman, Ahmed El Rhali, IRW Consulting 
Date: March 18th 2010
Time:  08.00-09.00 AM
Location: Wenner-Gren Center, floor 24

Breakfast starting from 07.45 AM

The seminar will be held in Swedish

Download invitation in swedish here.

Download presentations from Emma Wiman and Ahmed El Rhali from IRW Consulting